Journal of Clinical Epidemiology
Volume 54, Issue 12, Supplement 1 , Pages S3-S8 , December 2001

Justification for a new cohort study of people aging with and without HIV infection

  • A.C. Justice

      Affiliations

    • Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, University Drive C 11E-124 (130-U), Pittsburgh, PA 15240, USA
    • Veterans Aging Cohort Study (VACS) Center, Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    • Corresponding Author InformationCorresponding author. Tel.: 412-688-6957; fax: 412-688-6916. E-mail address:(A.C. Justice)
    • ,
  • C.S. Landefeld

      Affiliations

    • VA San Francisco Healthcare System and University of California San Francisoco School of Medicine, Division of Geriatrics, San Francisco, CA, USA
    • ,
  • S.M. Asch

      Affiliations

    • VA Los Angeles Healthcare System and University of California Los Angeles School of Medicine, Division of General Internal Medicine, Los Angeles, CA, USA
    • ,
  • A.L. Gifford

      Affiliations

    • VA San Diego Healthcare System and University of California San Diego School of Medicine, Division of General Internal Medicine, San Diego, CA, USA
    • ,
  • C.C. Whalen

      Affiliations

    • Case Western Reserve University School of Medicine, Division of Infectious Diseases and Department of Epidemiology, Cleveland, OH, USA
    • ,
  • K.E. Covinsky

      Affiliations

    • VA San Francisco Healthcare System and University of California San Francisoco School of Medicine, Division of Geriatrics, San Francisco, CA, USA

Received 24 July 2001 ,Revised 17 August 2001 ,Accepted 17 August 2001.

References 

  1. Justice AC, Whalen CC. Aging in AIDS; AIDS and aging. J Gen Intern Med. 1996;11:645–647
  2. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action on SEroConversion to AIDS and Death in Europe. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antitretroviral therapy (a collaborate re-analysis). Lancet. 2000;355:1131–1137
  3. Justice AC, Weissman S. The survival experience of older and younger adults with AIDS (is there a growing gap in survival?). Res Aging. 1998;20:665–685
  4. Justice AC, Aiken LH, Smith HL, Turner BJ. The role of functional status in predicting inpatient mortality with AIDS. J Clin Epidemiol. 1996;49:193–201
  5. Justice AC, Feinstein AR, Wells CK. A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med. 1989;320:1388–1393
  6. Justice AC, Chang C, Fusco J, for the CHORUS Program Team. Extrapolating long-term HIV/AIDS survival in the post HAART era. 39th Interscience Conference on antimicrobial agents and chemotherapy (ICAAC), Moscone Center, CA, 1999 [abstract].
  7. Ory M, Mack K. HIV/AIDS and aging: designing and evaluating interventions for older adults; epidemiology and clinical background. J Acquir Immune Defic Synd, in press.
  8. Reiter GS. Comprehensive clinical care:managing HIV as a chronic disease. AIDS clinical care (12 No. 2). Waltham, MA: Massachusetts Medical Society; 2000;p. 13–19.
  9. Chan ISF, Neaton JD, Saravolatz LD, Crane LR, Osterberger J, for the Communicty Programs for Clinical Research on AIDS. Frequencies of opportunistic diseases prior to death among HIV-infected persons. AIDS. 1995;9:1145–1151
  10. Munoz A, Schrager LK, Bacellar H, et al.  Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study (1985–1991). Am J Epidemiol. 1993;137:423–438
  11. Jones J, Hanson D, Dworkin M, et al.  Surveillance for AIDS-defining opportunistic illnesses, 1992–1997. Morb Mortal Wkly Rep. 1999;48:1–22
  12. Benhamou Y, Bochet M, Martino VD, et al.  Liver fibrosis progression in Human Immunodeficiency Virus and Hepatitis C virus coinfected patients. Hepatology. 1999;30:1054–1058
  13. Staples C, Rimland D, Dudas D. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) cohort study (HAVACS) (the effects of coinfection on survival). Clin Infect Dis. 1999;29:150–154
  14. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protese-inhibitor-associated lipodystrophy, hyperlipiddaemia, and diabetes mellitus (a cohort study). Lancet. 1999;353:2093–2099
  15. The Forum for Collaborative HIV Research. Metabolic abnormalities in HIV disease and treatment: the need for an interim case definition and a study to examine prevalence. The Forum for Collaborative HIV Research. The George Washington University Medical Center, The Forum for Collaborative HIV Research, 1999. p. 1–20.
  16. Moore RD, Fortgang I, Keruly J, Chaisson RE. Adverse events from drug therapy for human immunodeficiency virus disease. Am J Med. 1996;101:34–40
  17. Anonymous . Drugs for HIV infection. Med Lett. 2000;42:1–6
  18. Harrington M, Carpenter CCJ. Hit HIV-1 hard, but only when necessary. Lancet. 2000;355:2147–2152
  19. Lorenzi P, Yerly S, Abderrakim K, et al.  Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. AIDS. 1997;11:F95–F99
  20. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA. 2000;283:74–80
  21. Justice AC, Chang CC, Becker S, et al. Accuracy of CD4 cell count and viral load for predicting mortality in the post HAART era. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Moscone Center, CA, September 26, 1999. 1999 [abstract].
  22. Hinkin CH, Castellon SA, Atkinson JH, Goodkin K. Neuropsychiatric aspects of HIV-infection among older adults. J Clin Epidemiol. 2001;54:S44–S52
  23. Goodkin K, Wilkie FL, Concha M, et al.  Aging and neuro-AIDS conditions and the changing spectrum of HIV-1 associated morbidity and mortality. J Clin Epidemiol. 2001;54:S35–S43
  24. Kilbourne AM, Justice AC, Rabeneck L, Rodriquez-Barradas M, Weissman S, for the VACS, et al. General medical and psychiatric comorbidity among HIV infected veterans in the post-HAART era. J Clin Epidemiol. 2001;54:S22–S28
  25. Smola S, Justice ACfor the VACS 3 Project Team. Veterans Aging Cohort 3 Site Study (VACS 3). J Clin Epidemiol. 2001;54:S61–S76
  26. Thomas EJ, Studdert DM, Newhouse J, et al.  Costs of medical injuries in Utah and Colorado. Inquiry. 1999;36:255–264
  27. Brennan TA, Leape LL, Laird NM, et al.  Incidence of adverse events and negligence in hospitalized patients (results of the Harvard Medical Practice Study I). N Engl J Med. 1991;324:370–376
  28. Kohn LT, Corrigan JM, Donaldson MS, Committee on Quality of Health Care in America . To err is human (building a safer health system). Washington, DC: National Academy Press; 1999;
  29. Rothschild JM, Bates DW, Leape LL. Preventable medical injuries in older patients. Arch Intern Med. 2000;160:2717–2728
  30. Resnick NM, Marcantonio ER. How should clinical care of the aged differ?. Lancet. 1997;350:1157–1158
  31. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Eng J Med. 2000;342:1878–1886
  32. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Eng J Med. 2000;342:1887–1892
  33. Charlton BG. Randomized clinical trials (the worst kind of epidemiology?). Nat Med. 1995;1:1101–1102
  34. Hornberger J, Wrone E. When to base clinical policies on observational versus randomized trial data. Ann Intern Med. 1997;127:697–703
  35. Hu X, Wright J, McLeod R, Lossing A, Walters B. Observational studies as alternatives to randomized clinical trials in surgical clinical research. Surgey. 1996;19:473–475
  36. Rabeneck L, Viscoli C, Horwitz R. Problems in the conduct and analysis of randomized clinical trials (are we getting the right answers to the wrong questions?). Arch Intern Med. 1992;152:507–512
  37. Hlatky M, Califf R, Harrell F, Lee K, Mark DB, Pryor D. Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol. 1988;11:237–245
  38. Samet J, Munoz A. Evolution of the cohort study. Epidemiol Rev. 1998;20:1–14
  39. Samet J, Munoz A. Perspective (Cohort studies). Epidemiol Rev. 1998;20:135–136
  40. Peto R, Pike MC, Armitage P, et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer. 1976;34:585–612
  41. Babiker AG, Peto T, Porter K, Walker AS, Darbyshire JH. Age as a determinant of survival in Ageing and HIV. J Clin Epidemiol, in press.
  42. Howe G. Use of computerized record linkage in cohort studies. Epidemiol Rev. 1998;20:112–121
  43. Selby J. Linking automated databases for research in managed care. Ann Intern Med. 2000;127:719–724
  44. Cleary PD, Fowler FJ, Weissman JS, et al.  Health-related quality of life in persons with Acquiered Immune Deficiency Syndrome. Med Care. 1993;31:569–580
  45. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622–629
  46. Guyatt GH, Kirshner B, Jaeschke R. Measuring health status (what are the necessary measurement properties?). J Clin Epidemiol. 1992;45:1341–1345
  47. Justice AC, Chang CH, Rabeneck L, Zackin R. The clinical importance of provider-reported HIV symptoms compared to patient-report. Med Care. 2001;39:397–408
  48. Justice AC, Rabeneck L, Hays RD, Wu AW, Bozzette SA, for the Outcomes Committee of the AIDS, et al. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms (a comparison with self-reported symptoms). J Acquir Immune Defic Synd. 1999;21:126–133
  49. Kroenke K. Symptoms and science. The frontiers of primary care research. J Gen Intern Med. 1997;509–10:
  50. Sinclair G, Justice AC, Wagner J, Weissman S. HIV care providers do not appreciate the full range of their patients' symptoms. J Gen Intern Med. 1999;15:[abstract]
  51. Isaacson JH, Butler R, Zacharek M, Tzelepis A. Screening with the alcohol use disorders identification test (AUDIT) in an inner-city population. J Gen Intern Med. 1994;9:550–553
  52. Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J. Adherence (a necessity for sucessful HIV combination therapy). AIDS. 1999;in press:
  53. Chesney MA, Ickovics JR. Measuring adherence in AIDS Clinical Trials Group antiretroviral trials. Twenty-Third AIDS Clinical Trials Group Meeting. 1997;July 19–22:[abstract]
  54. Chesney MA, Ickovics JR, Chambers DB, et al.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials (the AACTG Adherence Instruments). AIDS Care. 2000;12:255–266
  55. Lebow JM, O'Connell JJ, Oddleifson S, Gallagher KM, Seage GRI, Freedberg KA. AIDS among the homeless of Boston (a cohort study). J Acq Immune Defic Synd Hum Retrovirol. 1995;8:292–296
  56. Flocke SA. Measuring attributes of primary care (development of a new instrument). J Fam Pract. 1997;45:64–74
  57. Flocke SA. Primary care instrument. J Fam Pract. 1998;46:
  58. Flocke SA, Stange KC, Zyzanski SJ. The association of attributes of primary care with the delivery of clincial preventive services. Med Care. 1998;36:AS21–AS30
  59. Flocke SA, Stange KC, Zyzanski SJ. The impact of insurance type and forced discontinuity on the delivery of primary care. J Fam Pract. 1997;45:129–135
  60. Stange KC, Jaén CR, Flocke SA, Miller WL, Crabtree BF, Zyzanski SJ. The value of a family physician. J Fam Pract. 1998;46:363–368
  61. Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG. Assessing illness severity (does clinical judgement work?). J Chron Dis. 1986;39:439–452
  62. Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG. Resuscitation (how do we decide? A prospective study of physicians' preferences and the clinical course of hospitalized patients). JAMA. 1986;255:1316–1322
  63. Knaus WA, Harrell FE, Lynn J, et al.  The SUPPORT prognostic model. Ann Intern Med. 1995;122:191–203
  64. McClish DK, Powell SH. How well can physicians estimate mortality in a medical intensive care unit?. Med Decis Making. 1989;9:125–132
  65. Pompei P, Charlson ME, Douglas RG. Clinical assessments as predictors of one year survival after hospitalization (implications for prognostic stratification). J Clin Epidemiol. 1988;41:275–284
  66. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care. 1993;31:141–154
  67. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis. 1974;27:387–404
  68. Kiefe CI, Funkhouser E, Fouad MN, May DS. Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med. 1998;13:357–365
  69. Redelmeirer DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516–1520
  70. Skiest DJ, Rubinstien E, Carley N, Gioiella L, Lyons R. The importance of comorbidity in HIV-infected patients over 55 (a retrospective case-control study). Am J Med. 1996;101:605–611
  71. van der Akker M, Buntinx F, Metsemakers JFM, Roos S, Knottnerus JA. Multimorbidity in general practice (prevalence, incidence, and determinants of co-occuring chronic and recurrent diseases). J Clin Epidemiol. 1998;51:367–375
  72. Welch HG, Albertsen PC, Nease RF, Bubolz TA, Wasson JH. Estimating treatment benefits for the elderly (the effect of competing risks). Ann Intern Med. 1996;124:577–584
  73. Leape LL, Woods DD, Hatlie MJ, Kizer KW, Schroeder SA, Lundberg GD. Promoting patient safety by preventing medical error. JAMA. 1998;280:1444–1447

PII: S0895-4356(01)00440-1

Journal of Clinical Epidemiology
Volume 54, Issue 12, Supplement 1 , Pages S3-S8 , December 2001

Article Tools

* Image Usage & Resolution